600 patients66,869 observations120 daysLIVE

Patient P-01737

Synthetic patientNBL-101 · Day 117 · 55–64 · F · baseline S14Open companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 44 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 44.

Primary contributors, last 14 days
  • Treatment adherence-7
  • GI instability-6
  • Toxicity+5
  • Nutritional resilience-2

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    92%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 83% showed improvement
    • median effect visible after 8 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 60
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 63 and rising
      • WearableSleep 5.4 h, below personal baseline
    • Inflammatory signalling 60
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 62
      • WearableHRV 19 ms, trending down
    • Butyrate / short-chain fatty acid production 45
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Drug metabolism and exposure 20
      • BloodToxicity index 55
    • Autonomic recovery 20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 1.8 · butyrate capacity 46/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    15 ms
    Sleep
    5.9 h
    Steps
    5,586
    Resting HR
    70 bpm
    Daily log: GI score 63, nutritional resilience 32, adherence 36.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0165555%S14GI-04no change29
    P-0176048%S1442
    P-0181347%S01NP-02no change40
    P-0160546%S14ME-01improved41
    P-0161946%S14GI-04worsened38
    P-0186646%S1440
    P-0179745%S14NP-02no change43
    P-0140744%S14NP-02no change44
    P-0176244%S14NP-02no change40
    P-0177644%S16NP-02no change47
    P-0156443%S14ME-01improved39
    P-0158243%S14GI-04no change45